Doctors Note Logo

Published on: 10/6/2026

Whether a plague vaccine is available in the United States

No plague vaccine is currently licensed or available in the United States, as the older killed whole-cell vaccine was discontinued in 1999 and newer candidates remain in clinical research. Because of this, protection relies on avoiding rodents and fleas, treating pets for fleas, and taking prescribed preventive antibiotics after a known exposure. Plague remains highly treatable when antibiotics begin early, so recognizing sudden fever, chills, weakness, or swollen and painful lymph nodes is critical. There are important details to consider, including exposure risk areas, post-exposure options, and which symptoms demand emergency care, so see below to understand more.

If you have been around rodents, flea bites, or sick animals and now feel feverish or notice a tender swollen gland, do not wait to guess what it means, because timing changes outcomes with illnesses like this; a free, instant, online symptom check can help you organize what you are feeling, understand possible causes, and decide whether to call your doctor or seek urgent care right now.

Last reviewed for medical accuracy: 10/06/2026

answer background

Explanation

Is a Plague Vaccine Available in the US?

Plague—caused by the bacterium Yersinia pestis—still exists in parts of the United States, primarily in rural areas of the Southwest. While modern antibiotics make treatment highly effective when started early, you might wonder: is a plague vaccine available in the US? In short, there is currently no FDA-licensed plague vaccine for general public use. Below, we’ll review the facts, history, ongoing research, and what you can do to protect yourself.

Current Status: No Licensed Vaccine for Public Use

Despite decades of research, no plague vaccine available US citizens can obtain through routine medical care. Key points:

  • The U.S. Food and Drug Administration (FDA) has not approved any plague vaccine for widespread civilian use.
  • An inactivated (killed) plague vaccine was once offered to select laboratory and military personnel, but production stopped in 1999.
  • Today, plague vaccines remain experimental or limited to Investigational New Drug (IND) protocols for high-risk professionals.

History of Plague Vaccines in the United States

  1. Inactivated Vaccine (1950s–1999)
    • Developed by Wyeth and later produced by Aventis Pasteur.
    • Administered by injection to laboratory workers and military staff handling Y. pestis.
    • Discontinued due to side effects and only moderate protection against pneumonic plague.
  2. Live-Attenuated Vaccines
    • Used in some countries but not licensed by the FDA.
    • Research halted because of safety concerns.
  3. Recombinant Subunit Vaccines
    • Focus on bacterial proteins (F1 and V antigens).
    • Promising results in animal studies; human trials ongoing under INDs.

Why Isn’t a Plague Vaccine Widely Available?

  • Low Case Numbers: The U.S. sees fewer than 10 human plague cases per year on average.
  • Effective Treatment: Early antibiotic therapy (streptomycin, gentamicin, doxycycline) typically cures plague.
  • Safety & Efficacy: Developing a vaccine that is both safe and broadly protective against all plague forms (bubonic, pneumonic, septicemic) is challenging.

Plague in the United States: What You Need to Know

Though rare, plague still occurs in the U.S., mostly in rural parts of Arizona, California, Colorado, and New Mexico. Recent trends:

  • Average of 7 human cases annually; outbreaks can happen among wildlife or domestic animals.
  • Rodents (prairie dogs, squirrels) and their fleas are the usual culprits.
  • Pneumonic plague (lung infection) is the most serious form and can spread between people via droplets.

Common Symptoms by Type

  • Bubonic plague: fever, chills, headache, swollen lymph nodes (“buboes”)
  • Pneumonic plague: high fever, cough, chest pain, difficulty breathing
  • Septicemic plague: fever, abdominal pain, bleeding under the skin

Preventing Plague Without a Vaccine

Since there’s no plague vaccine available US residents can access, focus on practical prevention:

• Avoid handling wild rodents or sick/dead animals.
• Use insect repellent containing DEET or permethrin-treated clothing to repel fleas.
• Keep pets treated for fleas, especially if they roam outdoors.
• Seal up homes to prevent rodent entry; store food and waste securely.
• Wear gloves when cleaning areas with rodent droppings.

Ongoing Research: Toward Future Vaccines

Scientists continue working on better plague vaccines, aiming for:

  • Strong immunity against multiple plague forms.
  • Minimal side effects and longer-lasting protection.
  • Deliverable as a simple injection or nasal spray.

Several candidates (recombinant protein and live-attenuated) are in advanced animal studies and early human trials. Until one gains FDA approval, these remain off-label or experimental, under strict IND protocols.

What to Do If You Suspect Plague

• Watch for sudden fever, chills, swollen lymph nodes, or severe cough if you’ve been in an area with rodent activity.
• Seek medical care immediately—early antibiotic treatment is lifesaving.
• Consider a free, online symptom check, using the doctor approved Ubie Symptom Checker for guidance on whether you need urgent evaluation.
• Tell your healthcare provider about any animal exposures or travel history.

Key Takeaways

  • No plague vaccine available US civilians can access today.
  • Historical vaccines were limited to high-risk lab and military personnel.
  • Antibiotics remain the cornerstone of prevention and treatment.
  • Ongoing research may one day yield an FDA-approved vaccine.
  • Prevent infection by avoiding fleas and rodents, and treat suspected cases without delay.

Always remember: if you have symptoms or concerns that could be life-threatening or serious, speak to a doctor right away. Your healthcare provider can order appropriate tests, start treatment, and advise on preventing infection.

(References)

  • * Inglesby TV, Dennis DT, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Friedlander AM, Hauer J, Koerner JF, Layton M, McDade J, Osterholm MT, O'Toole T, Parker G, Perl TM, Russell PK, Schoch-Spana M, Tonat K. Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA. 2000 May 3;283(17):2281-90. doi: 10.1001/jama.283.17.2281. PMID: 10807389.

  • * Lutwick LI, Nierengarten MB. Vaccines for Category A bioterrorism diseases. Expert Opin Biol Ther. 2002 Dec;2(8):883-93. doi: 10.1517/14712598.2.8.883. PMID: 12517267.

  • * Prentice MB, Rahalison L. Plague. Lancet. 2007 Apr 7;369(9568):1196-207. doi: 10.1016/S0140-6736(07)60566-2. PMID: 17416264.

  • * Cornelius CA, Quenee LE, Overheim KA, Koster F, Brasel TL, Elli D, Ciletti NA, Schneewind O. Immunization with recombinant V10 protects cynomolgus macaques from lethal pneumonic plague. Infect Immun. 2008 Dec;76(12):5588-97. doi: 10.1128/IAI.00699-08. Epub 2008 Sep 15. PMID: 18794281; PMCID: PMC2583586.

  • * Butler T. Plague into the 21st century. Clin Infect Dis. 2009 Sep 1;49(5):736-42. doi: 10.1086/604718. PMID: 19606935.

  • * Williamson ED. Plague. Vaccine. 2009 Nov 5;27 Suppl 4:D56-60. doi: 10.1016/j.vaccine.2009.07.068. PMID: 19837288.

  • * Williamson ED, Oyston PC. Protecting against plague: towards a next-generation vaccine. Clin Exp Immunol. 2013 Apr;172(1):1-8. doi: 10.1111/cei.12044. PMID: 23480179; PMCID: PMC3719925.

  • * Fan Y, Sahdev P, Ochyl LJ, Akerberg J, Moon JJ. Cationic liposome-hyaluronic acid hybrid nanoparticles for intranasal vaccination with subunit antigens. J Control Release. 2015 Jun 28;208:121-129. doi: 10.1016/j.jconrel.2015.04.010. Epub 2015 Apr 11. PMID: 25869965; PMCID: PMC4430437.

  • * Sebbane F, Uversky VN, Anisimov AP. Yersinia pestis Plasminogen Activator. Biomolecules. 2020 Nov 14;10(11). doi: 10.3390/biom10111554. Epub 2020 Nov 14. PMID: 33202679; PMCID: PMC7696990.

  • * Rosenzweig JA, Hendrix EK, Chopra AK. Plague vaccines: new developments in an ongoing search. Appl Microbiol Biotechnol. 2021 Jun;105(12):4931-4941. doi: 10.1007/s00253-021-11389-6. Epub 2021 Jun 18. PMID: 34142207; PMCID: PMC8211537.

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.